BioSpace News Archive

Data development plan review continues with FDA under Breakthrough Device designation process; Performance meets or exceeds targets for identifying rapid kidney function decline in patients with Type 2 diabetes and existing chronic kidney disease

BioMarin Pharmaceutical Inc., a global leader in providing therapies for rare genetic diseases, announced the appointment of pharmaceutical veteran and former Johnson & Johnson executive, Liz McKee Anderson, to its Board of Directors effective July 15th, 2019.

ReachBio Research Labs, a CRO specializing in primary cell assay services and products, is now offering off-target toxicity and linker stability assay services for antibody drug conjugates.

Exact Sciences Corp. announced that the company will host webcasts and conference calls of its annual stockholders meeting and its second-quarter 2019 financial results.

Aerie Pharmaceuticals, Inc. announced that enrollment for its Phase 2 clinical trial of netarsudil ophthalmic solution in Japan is complete, a milestone reached several months earlier than previously anticipated.

EIP Pharma, Inc., a CNS-focused therapeutics company, announced the initiation of a new Phase 2 proof-of-concept study evaluating neflamapimod as a treatment for the cognitive dysfunction associated with Huntington’s disease, a rare, genetically inherited disease that causes the nerve cells of the brain to progressively degenerate.

First Biomimetic Model to Demonstrate Myelination of Human Nerve Cells with Human Schwann Cells

Medicenna Therapeutics Corp., a clinical stage immuno-oncology company, announced that it has received US$1,915,264 from the Cancer Prevention and Research Institute of Texas.

Sigilon Therapeutics presented preclinical data demonstrating the feasibility of cellular therapies for bleeding disorders developed with the company’s Shielded Living Therapeutics™ platform, which was designed to deliver functional cures for chronic diseases.

Personalized brain neuromodulation technology provides relief from debilitating migraine symptoms